Stay updated on EDP-305 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the EDP-305 Safety and Efficacy in NASH Clinical Trial page
- Check3 days agoChange DetectedThe page now includes the 2019 NIH grant/contract attribution. The site revision has been updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now displays an error indicating the content is unavailable, preventing access to the study details. Added study documents and metadata (Protocol PDF, SPA PDF, IPD plan, and related information) to provide additional resources when the page loads correctly.SummaryDifference98%

- Check25 days agoChange DetectedThe page now displays Revision: v3.6.5, signaling a newer site version, and the older Revision: v3.6.4 label has been removed.SummaryDifference18%

- Check39 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page’s documentation/version rather than to its content.SummaryDifference0.0%

- Check46 days agoChange DetectedFatty Liver Disease was replaced with Steatotic Liver Disease on the page to reflect updated nomenclature for liver fat–related conditions. This terminology change updates how the condition is described and searched within the study context.SummaryDifference0.0%

- Check60 days agoChange DetectedA new site revision label, v3.6.3, appears on the page. This indicates a platform update and does not modify the study details or user-facing actions.SummaryDifference0.0%

Stay in the know with updates to EDP-305 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.